United States HR 4640: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-10-14)

State: United States · Session: 116 · Bill: HR 4640

Subjects: Drug safety, medical device, and laboratory regulation, Health programs administration and funding, Health technology, devices, supplies, Inflation and prices, Intellectual property, Medical research, Research and development

Sponsors: PETER A. DEFAZIO, Chellie Pingree, JANICE D. SCHAKOWSKY, Jesus G. Garcia, LLOYD DOGGETT, MARCY KAPTUR, Mark Pocan, Peter Welch, ROSA DELAURO, Raul M. Grijalva, Ro Khanna, Steve Cohen

View United States HR 4640 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.